太龙药业: 太龙药业关于选举职工代表董事的公告

Core Viewpoint - The announcement details the election of a new employee representative director, Chen Fengyun, at Henan Tailong Pharmaceutical Co., Ltd., as part of the company's governance structure [1][2]. Group 1: Election Announcement - Henan Tailong Pharmaceutical Co., Ltd. will elect Chen Fengyun as an employee representative director during the third extraordinary general meeting of shareholders in 2025 [1]. - Chen Fengyun will join the eight directors elected at the same meeting to form the company's tenth board of directors, with a term aligned with that board [1]. Group 2: Qualifications of the New Director - Chen Fengyun meets all legal and regulatory requirements for the position of director, with no disqualifications under the Company Law or the company's articles of association [1]. - There are no current restrictions on Chen Fengyun's ability to serve as a director, including any sanctions from the China Securities Regulatory Commission or recognition by stock exchanges as unsuitable for the role [1]. Group 3: Background of Chen Fengyun - Chen Fengyun, born in January 1978, holds a bachelor's degree and is a member of the Communist Party of China, as well as a senior accountant [2]. - She has held various positions within the company, including Deputy Manager of the Planning Audit Department and Director of the Budget and Financial Management Center [2].